Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Neurology Rheumatology Diabetes / Metabolic Mental Health / Psychiatry Women's Health Dermatology Men's Health Rare Diseases
Trial Radar • ClinicalTrials.gov • Registry-linked

Trial Radar

1003 clinical trials with phase, status, specialty and registry links, summarised for rapid clinical review.

1003 recruiting AI clinical summaries
Explore Trial Collections Follow research updates
All Phases Phase I Phase II Phase III Phase IV
Therapeutic Area: All Cardiology / Cardiovascular Dermatology Diabetes / Metabolic Gastroenterology Haematology Infectious Disease Men's Health Mental Health / Psychiatry Nephrology Neurology Oncology Rare Diseases
🔬
Trial Radar

Clinical Trial Intelligence

● Recruiting Phase III Respiratory / COPD / Asthma
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to is Recruiting • Phase III • Respiratory / COPD /…
25 Mar 2026 NCT06191315
● Recruiting Phase IV Respiratory / COPD / Asthma
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma is Recruiting…
25 Mar 2026 NCT05097287
● Recruiting Phase I Respiratory / COPD / Asthma
RIG 101 Trial in Healthy Adults and Adults With Asthma
RIG 101 Trial in Healthy Adults and Adults With Asthma is Recruiting • Phase I • Respiratory / COPD / Asthma • NCT07488897. Nested…
25 Mar 2026 NCT07488897
● Recruiting Phase II Respiratory / COPD / Asthma
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma is Recruiting • Phase II • Respiratory / COPD / Asthma •…
25 Mar 2026 NCT06676319
● Recruiting Phase IV Respiratory / COPD / Asthma
Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil Levels
Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil Levels is Recruiting • Phase IV • Respiratory /…
25 Mar 2026 NCT06334575
● Recruiting Phase III Respiratory / COPD / Asthma
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an…
25 Mar 2026 NCT07190209
● Recruiting Phase II Respiratory / COPD / Asthma
A Study to Evaluate Solrikitug in Participants With COPD (ZION)
A Study to Evaluate Solrikitug in Participants With COPD (ZION) is Recruiting • Phase II • Respiratory / COPD / Asthma • NCT06496620. A…
25 Mar 2026 NCT06496620
● Recruiting Phase III Respiratory / COPD / Asthma
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an…
25 Mar 2026 NCT07190222
● Recruiting Phase IV Oncology
A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and Hyperinflation
A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in…
25 Mar 2026 NCT07073950
● Recruiting Phase II Respiratory / COPD / Asthma
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease is Recruiting • Phase II…
25 Mar 2026 NCT07082738
● Recruiting Respiratory / COPD / Asthma
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema is Recruiting • Phase not applicable • Respiratory…
25 Mar 2026 NCT06035120
● Recruiting Cardiology / Cardiovascular
PulseSelect™ PFA Global Registry
PulseSelect™ PFA Global Registry is Recruiting • Phase not applicable • Cardiology / Cardiovascular • NCT06393920. The PulseSelect™ PFA Global Registry is a prospective,…
25 Mar 2026 NCT06393920
● Recruiting Cardiology / Cardiovascular
Rate or Rhythm Control in CRT: the RHYTHMIC Study
Rate or Rhythm Control in CRT: the RHYTHMIC Study is Recruiting • Phase not applicable • Cardiology / Cardiovascular • NCT04664686. 70 patients with…
25 Mar 2026 NCT04664686
● Recruiting Phase III Cardiology / Cardiovascular
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG is Recruiting • Phase III • Cardiology / Cardiovascular • NCT04045665. The primary objective of this…
25 Mar 2026 NCT04045665
● Recruiting Phase III Cardiology / Cardiovascular
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI…
25 Mar 2026 NCT05712200
● Recruiting Phase II Cardiology / Cardiovascular
A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation
A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation is Recruiting • Phase II • Cardiology…
25 Mar 2026 NCT07217067
● Recruiting Cardiology / Cardiovascular
Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy
Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy is Recruiting • Phase not applicable •…
25 Mar 2026 NCT05976685
● Recruiting Cardiology / Cardiovascular
The Fourth Left Atrial Appendage Occlusion Study
The Fourth Left Atrial Appendage Occlusion Study is Recruiting • Phase not applicable • Cardiology / Cardiovascular • NCT05963698. LAAOS-4 aims to determine if…
25 Mar 2026 NCT05963698
● Recruiting Cardiology / Cardiovascular
A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation Catheter in the Treatment of Atrial Fibrillation
A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation Catheter in the Treatment of…
25 Mar 2026 NCT06808217
● Recruiting Phase III Cardiology / Cardiovascular
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure is Recruiting • Phase III • Cardiology / Cardiovascular…
25 Mar 2026 NCT06424288
● Recruiting Cardiology / Cardiovascular
Development of Novel Physiological CMR Methods in Health and Disease
Development of Novel Physiological CMR Methods in Health and Disease is Recruiting • Phase not applicable • Cardiology / Cardiovascular • NCT03854071. Physiological cardiovascular…
25 Mar 2026 NCT03854071
● Recruiting Phase II Cardiology / Cardiovascular
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF) is Recruiting • Phase II • Cardiology /…
25 Mar 2026 NCT06991257
● Recruiting Cardiology / Cardiovascular
The Use of Advanced Imaging in HFpEF
The Use of Advanced Imaging in HFpEF is Recruiting • Phase not applicable • Cardiology / Cardiovascular • NCT06905405. Heart failure with preserved ejection…
25 Mar 2026 NCT06905405
● Recruiting Phase III Cardiology / Cardiovascular
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function is Recruiting • Phase III • Cardiology /…
25 Mar 2026 NCT06307652
● Recruiting Phase III Cardiology / Cardiovascular
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to…
25 Mar 2026 NCT07207811
● Recruiting Phase III Cardiology / Cardiovascular
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the…
25 Mar 2026 NCT06935370
● Recruiting Phase II Cardiology / Cardiovascular
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036) is Recruiting • Phase II…
25 Mar 2026 NCT05714085
● Recruiting Phase II Oncology
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) is Recruiting • Phase II •…
25 Mar 2026 NCT05489211
● Recruiting Phase II Oncology
A Phase II Trial of Neoadjuvant PD-1 Vaccine PD1-Vaxx in Operable MSI High Colorectal Cancer
A Phase II Trial of Neoadjuvant PD-1 Vaccine PD1-Vaxx in Operable MSI High Colorectal Cancer is Recruiting • Phase II • Oncology • NCT06692959.…
25 Mar 2026 NCT06692959
● Recruiting Phase III Oncology
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012) is Recruiting • Phase III • Oncology…
25 Mar 2026 NCT06997497
● Recruiting Phase III Oncology
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite…
25 Mar 2026 NCT07284849
● Recruiting Phase III Oncology
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003) is Recruiting • Phase III • Oncology • NCT06136624. This is a phase 3,…
25 Mar 2026 NCT06136624
● Recruiting Men's Health
Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions
Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions is Recruiting • Phase not applicable • Men's Health, Oncology • NCT06638541. DESTINATION…
25 Mar 2026 NCT06638541
● Recruiting Phase III Oncology
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC. is Recruiting • Phase III • Oncology • NCT05939414. The…
25 Mar 2026 NCT05939414
● Recruiting Phase III Men's Health
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer. is Recruiting • Phase III • Men's Health, Oncology…
25 Mar 2026 NCT06629779
● Recruiting Phase I Men's Health
Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)
Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A) is Recruiting…
25 Mar 2026 NCT06353386
● Recruiting Phase III Men's Health
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004) is Recruiting •…
25 Mar 2026 NCT06136650
● Recruiting Phase II Oncology
A Study of BMS-986504 in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion (MountainTAP-9)
A Study of BMS-986504 in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion (MountainTAP-9) is Recruiting •…
25 Mar 2026 NCT06855771
● Recruiting Respiratory / COPD / Asthma
European Real-World Registry for Use of the Ion Endoluminal System
European Real-World Registry for Use of the Ion Endoluminal System is Recruiting • Phase not applicable • Respiratory / COPD / Asthma • NCT06923774.…
25 Mar 2026 NCT06923774
● Recruiting Phase III Oncology
Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial
Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial is Recruiting • Phase III • Oncology • NCT05072314. The LOLIPOP Trial is a…
25 Mar 2026 NCT05072314
● Recruiting Phase III Oncology
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer is Recruiting • Phase III • Oncology • NCT07173751. This…
25 Mar 2026 NCT07173751
● Recruiting Phase II Oncology
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1…
25 Mar 2026 NCT06926868
● Recruiting Phase II Oncology
Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029)
Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029) is Recruiting • Phase II • Oncology • NCT06428396. The purpose of…
25 Mar 2026 NCT06428396
● Recruiting Phase III Oncology
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA) is Recruiting • Phase…
25 Mar 2026 NCT07174336
● Recruiting Phase I Oncology
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies is Recruiting • Phase I • Oncology •…
25 Mar 2026 NCT05123482
● Recruiting Phase I Cardiology / Cardiovascular
A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer’s Disease
A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer’s Disease is Recruiting • Phase I • Cardiology / Cardiovascular • NCT06297590. The…
25 Mar 2026 NCT06297590
● Recruiting Phase II Cardiology / Cardiovascular
A Clinical Study of MK-2214 in People With Early Alzheimer’s Disease (MK-2214-004)
A Clinical Study of MK-2214 in People With Early Alzheimer’s Disease (MK-2214-004) is Recruiting • Phase II • Cardiology / Cardiovascular • NCT07033494. Researchers…
25 Mar 2026 NCT07033494
● Recruiting Phase III Respiratory / COPD / Asthma
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer’s Disease
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer’s Disease is Recruiting • Phase III • Respiratory / COPD / Asthma •…
25 Mar 2026 NCT07170150
● Recruiting Phase III Cardiology / Cardiovascular
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2) is Recruiting • Phase III • Cardiology…
25 Mar 2026 NCT06516965
● Recruiting Phase III Oncology
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer’s Disease (ADAGIO-3)
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer’s Disease (ADAGIO-3) is Recruiting • Phase III…
25 Mar 2026 NCT06937229